Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Change in Cash (2017 - 2025)

Skinvisible (SKVI) has disclosed Change in Cash for 15 consecutive years, with $1975.0 as the latest value for Q4 2025.

  • Quarterly Change in Cash fell 79.69% to $1975.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$7716.0 through Dec 2025, down 181.67% year-over-year, with the annual reading at -$7716.0 for FY2025, 181.67% down from the prior year.
  • Change in Cash hit $1975.0 in Q4 2025 for Skinvisible, up from $525.0 in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $135239.0 in Q2 2022 to a low of -$52240.0 in Q1 2023.
  • Historically, Change in Cash has averaged -$1663.8 across 5 years, with a median of -$1962.0 in 2023.
  • Biggest five-year swings in Change in Cash: surged 6093.63% in 2024 and later plummeted 1099.28% in 2025.
  • Year by year, Change in Cash stood at $16814.0 in 2021, then plummeted by 373.79% to -$46035.0 in 2022, then skyrocketed by 100.34% to $157.0 in 2023, then soared by 6093.63% to $9724.0 in 2024, then crashed by 79.69% to $1975.0 in 2025.
  • Business Quant data shows Change in Cash for SKVI at $1975.0 in Q4 2025, $525.0 in Q3 2025, and -$13276.0 in Q2 2025.